Literature DB >> 19826048

Candidate gene association study of esophageal squamous cell carcinoma in a high-risk region in Iran.

Mohammad R Akbari1, Reza Malekzadeh, Ramin Shakeri, Dariush Nasrollahzadeh, Maryam Foumani, Yulong Sun, Akram Pourshams, Alireza Sadjadi, Elham Jafari, Masoud Sotoudeh, Farin Kamangar, Paolo Boffetta, Sanford M Dawsey, Parviz Ghadirian, Steven A Narod.   

Abstract

There is a region with a high risk for esophageal squamous cell carcinoma (ESCC) in the northeast of Iran. Previous studies suggest that hereditary factors play a role in the high incidence of cancer in the region. We selected 22 functional variants (and 130 related tagSNPs) from 15 genes that have been associated previously with the risk of ESCC. We genotyped a primary set of samples from 451 Turkmens (197 cases and 254 controls). Seven of 152 variants were associated with ESCC at the P = 0.05 level; these single nucleotide polymorphisms were then studied in a validation set of 549 cases and 1,119 controls, which included both Turkmens and non-Turkmens. The association observed for a functional variant in ADH1B was confirmed in the validation set, and that of a tagSNP in MGMT, the association was borderline significant in the validation set, after correcting for multiple testing. The other 5 variants that were associated in the primary set were not significantly associated in the validation set. The histidine allele at codon 48 of ADH1B gene was associated with a significantly decreased risk of ESCC in the joint data set (primary and validation set) under a recessive model (odds ratio, 0.41; 95% confidence interval, 0.29-0.76; P = 4 x 10(-4)). The A allele of the rs7087131 variant of MGMT gene was associated with a decreased risk of ESCC under a dominant model (odds ratio, 0.79; 95% confidence interval, 0.64-0.96; P = 0.02). These results support the hypothesis that genetic predisposition plays a role in the high incidence of ESSC in Iran.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19826048      PMCID: PMC3505030          DOI: 10.1158/0008-5472.CAN-09-1149

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  60 in total

1.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

2.  Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma.

Authors:  M R Akbari; R Malekzadeh; D Nasrollahzadeh; D Amanian; F Islami; S Li; I Zandvakili; R Shakeri; M Sotoudeh; K Aghcheli; R Salahi; A Pourshams; S Semnani; P Boffetta; S M Dawsey; P Ghadirian; S A Narod
Journal:  Oncogene       Date:  2007-08-27       Impact factor: 9.867

3.  Genetic polymorphisms, messenger RNA expression of p53, p21, and CCND1, and possible links with chromosomal aberrations in Chinese vinyl chloride-exposed workers.

Authors:  Yu-lan Qiu; Wei Wang; Tong Wang; Jing Liu; Pin Sun; Ji Qian; Li Jin; Zhao-lin Xia
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10       Impact factor: 4.254

4.  Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study.

Authors:  Y Zheng; H Shen; E M Sturgis; L E Wang; S A Eicher; S S Strom; M L Frazier; M R Spitz; Q Wei
Journal:  Carcinogenesis       Date:  2001-08       Impact factor: 4.944

5.  High urine 1-hydroxypyrene glucuronide concentrations in Linxian, China, an area of high risk for squamous oesophageal cancer.

Authors: 
Journal:  Biomarkers       Date:  2001       Impact factor: 2.658

Review 6.  Roles of electrophilic sulfuric acid ester metabolites in mutagenesis and carcinogenesis by some polynuclear aromatic hydrocarbons.

Authors:  Y J Surh; J A Miller
Journal:  Chem Biol Interact       Date:  1994-06       Impact factor: 5.192

7.  Association between CCND1 G/A870 polymorphism, allele-specific amplification, cyclin D1 expression, and survival in esophageal and lung carcinoma.

Authors:  Vanita K Gupta; Andrew Feber; Liqiang Xi; Arjun Pennathur; Maoxin Wu; James D Luketich; Tony E Godfrey
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

8.  CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.

Authors:  K M Sathyan; K R Nalinakumari; Thomas Abraham; S Kannan
Journal:  Oral Oncol       Date:  2007-12-03       Impact factor: 5.337

9.  Relevance of N-nitrosamines to oesophageal cancer in China.

Authors:  S H Lu; S X Chui; W X Yang; X N Hu; L P Guo; F M Li
Journal:  IARC Sci Publ       Date:  1991

10.  P53 germ line haplotypes associated with increased risk for colorectal cancer.

Authors:  A Själander; R Birgander; L Athlin; R Stenling; J Rutegård; L Beckman; G Beckman
Journal:  Carcinogenesis       Date:  1995-07       Impact factor: 4.944

View more
  21 in total

Review 1.  Two DNA repair gene polymorphisms on the risk of gastrointestinal cancers: a meta-analysis.

Authors:  Yue Hu; Min Zhou; Kang Li; Kai Zhang; Xiangquan Kong; Yamei Zheng; Jianxu Li; Li Liu
Journal:  Tumour Biol       Date:  2013-11-08

2.  Common genetic variants related to genomic integrity and risk of papillary thyroid cancer.

Authors:  Gila Neta; Alina V Brenner; Erich M Sturgis; Ruth M Pfeiffer; Amy A Hutchinson; Briseis Aschebrook-Kilfoy; Meredith Yeager; Li Xu; William Wheeler; Michael Abend; Elaine Ron; Margaret A Tucker; Stephen J Chanock; Alice J Sigurdson
Journal:  Carcinogenesis       Date:  2011-06-03       Impact factor: 4.944

Review 3.  A systematic review and meta-analysis of the association between OGG1 Ser326Cys polymorphism and cancers.

Authors:  Ping-Ting Zhou; Bo Li; Jun Ji; Meng-Meng Wang; Chun-Fang Gao
Journal:  Med Oncol       Date:  2015-01-15       Impact factor: 3.064

4.  Gene-environment interactions on the risk of esophageal cancer among Asian populations with the G48A polymorphism in the alcohol dehydrogenase-2 gene: a meta-analysis.

Authors:  Long Zhang; Yingjiu Jiang; Qingcheng Wu; Qiang Li; Dan Chen; Ling Xu; Cheng Zhang; Min Zhang; Ling Ye
Journal:  Tumour Biol       Date:  2014-01-21

5.  CircGOT1 promotes cell proliferation, mobility, and glycolysis-mediated cisplatin resistance via inhibiting its host gene GOT1 in esophageal squamous cell cancer.

Authors:  Shasha Zhou; Zhiyuan Guo; Xueli Lv; Xueqiang Zhang
Journal:  Cell Cycle       Date:  2021-12-17       Impact factor: 4.534

6.  ADH1B Arg47His polymorphism is associated with esophageal cancer risk in high-incidence Asian population: evidence from a meta-analysis.

Authors:  Guohong Zhang; Ruiqin Mai; Bo Huang
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

7.  Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions.

Authors:  Chen Wu; Peter Kraft; Kan Zhai; Jiang Chang; Zhaoming Wang; Yun Li; Zhibin Hu; Zhonghu He; Weihua Jia; Christian C Abnet; Liming Liang; Nan Hu; Xiaoping Miao; Yifeng Zhou; Zhihua Liu; Qimin Zhan; Yu Liu; Yan Qiao; Yuling Zhou; Guangfu Jin; Chuanhai Guo; Changdong Lu; Haijun Yang; Jianhua Fu; Dianke Yu; Neal D Freedman; Ti Ding; Wen Tan; Alisa M Goldstein; Tangchun Wu; Hongbing Shen; Yang Ke; Yixin Zeng; Stephen J Chanock; Philip R Taylor; Dongxin Lin
Journal:  Nat Genet       Date:  2012-09-09       Impact factor: 38.330

8.  The polymorphisms in the MGMT gene and the risk of cancer: a meta-analysis.

Authors:  Liang Du; Haichuan Wang; Tianyuan Xiong; Yaxian Ma; Jiqiao Yang; Jichong Huang; Dong Zeng; Xiaoze Wang; He Huang; Jin Huang
Journal:  Tumour Biol       Date:  2013-06-13

9.  CCND1 G870A polymorphism contributes to the risk of esophageal cancer: An updated systematic review and cumulative meta-analysis.

Authors:  Li Wen; Yuan-Yuan Hu; Gong-Li Yang; DE-Xi Liu
Journal:  Biomed Rep       Date:  2014-05-21

10.  Lack of association between cyclin D1 A870G (rs9344) polymorphism and esophageal squamous cell carcinoma risk: case-control study and meta-analysis.

Authors:  Weifeng Tang; Ping Yu; Yafeng Wang; Mingqiang Kang; Bin Sun; Jun Yin; Haiyong Gu
Journal:  Int J Clin Exp Med       Date:  2015-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.